<DOC>
	<DOCNO>NCT02268942</DOCNO>
	<brief_summary>This prospective , multi-center , single arm study evaluate thoracotomy implant technique 145 subject implant via thoracotomy HeartWare HVAD® System enrol Interagency Registry Mechanically Assisted Circulatory Support ( INTERMACS® ) protocol database . All participate center current INTERMACS® site good stand follow INTERMACS® protocol procedure .</brief_summary>
	<brief_title>A Prospective , Single Arm , Multi-Center Clinical Study Collaboration With Interagency Registry Mechanically Assisted Circulatory Support ( INTERMACS® ) Evaluate Thoracotomy Implant Technique HeartWare HVAD® System Patients With Advanced Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>1 . Must ≥19 year age time inform consent participate INTERMACS® registry . 2 . Subject receive HeartWare® HVAD ( The device subject 's first VAD implant ) . 3 . Subject sign INTERMACS® inform consent require local IRB policy . 4 . Subject sign HeartWare ®informed consent . 1 . Subject incarcerate ( prisoner ) . 2 . Subject sign inform consent sit waiver consent grant . 3 . Body Surface Area ( BSA ) &lt; 1.2 m^2 . 4 . Prior cardiac transplant cardiomyoplasty . 5 . Subject receive BiVAD . 6 . Subject receive device RVAD . 7 . Subject data generate non INTERMACS® center . 8 . Pediatric subject ( &lt; 19 year age ) . 9 . Subjects receive temporary LVAD 10 . Subjects whose device strategy list `` Destination Therapy '' time implant . 11 . Severe Right Heart failure 12 . Aortic insufficiency mechanical aortic valve . 13 . Planned concomitant procedure ( e.g.valve repair replacement , CABG , septal defect repair ) . 14 . Known LV Thrombus .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>